PMID: 7035687Jan 1, 1982Paper

A prospective study of prophylactic penicillin in acutely burned hospitalized patients

The Journal of Trauma
M B DurtschiD M Heimbach

Abstract

The use of prophylactic low-dose penicillin acutely burned, hospitalized patients remains controversial. Fifty-one adult patients with burns of 1% to 91% total body surface area were prospectively studied to determine the efficacy of prophylactic penicillin in the prevention of wound cellulitis and burn wound sepsis, and to examine the influence of prophylactic penicillin on the emergence of antibiotic resistant microorganisms. In 25 patients given a 5-day course of penicillin prophylactically, 11 developed cellulitis and two had burn wound sepsis. A similar group of patients given placebo developed seven cases of cellulitis and three cases of burn wound sepsis (p = 0.340). No patient in either group developed gentamicin-resistant Gram-negative organisms, although the gastrointestinal tracts of two patients in the penicillin group showed new colonization by yeast. We conclude that the routine administration of prophylactic penicillin neither protects against cellulitis and burn wound sepsis, nor promotes selection of antibiotic-resistant bacteria in hospitalized patients with acute thermal injury.

Citations

Dec 1, 1988·Annals of Emergency Medicine·C R Baxter, J F Waeckerle
May 1, 1997·Burns : Journal of the International Society for Burn Injuries·B G Sparkes
May 14, 1999·Burns : Journal of the International Society for Burn Injuries·R L BangA R Lari
Feb 28, 2009·Surgical Infections·Kevin M SchusterNicholas Namias
Oct 9, 2009·Surgical Infections·Ludwik K BranskiDavid N Herndon
Feb 17, 2010·BMJ : British Medical Journal·Tomer AvniMical Paul
Mar 10, 1998·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·D Duke, J M Grevelink
Jul 5, 2011·Burns : Journal of the International Society for Burn Injuries·Merlin GuggenheimBernhard Guggenheim
Sep 26, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Takashi TagamiHideo Yasunaga
Jul 28, 1986·The American Journal of Medicine·A LutermanP W Curreri
Feb 1, 1988·The Journal of Hospital Infection·T Sacks
Aug 12, 2015·International Journal of Surgery·Barclay T StewartNicole Gibran
Jun 3, 2009·FEMS Immunology and Medical Microbiology·Mirjam Kooistra-SmidHenri Verbrugh
Apr 1, 1988·Critical Care Clinics·M C Robson
Aug 8, 2014·Journal of Burn Care & Research : Official Publication of the American Burn Association·Jason P HeardLucy A Wibbenmeyer
Sep 18, 2013·Journal of Burn Care & Research : Official Publication of the American Burn Association·Amir IbrahimJeremy Goverman
Aug 9, 2001·The Journal of Trauma·R L SheridanR G Tompkins
Jun 7, 2013·The Cochrane Database of Systematic Reviews·Leticia A Barajas-NavaXavier Bonfill Cosp
Apr 1, 1995·The British Journal of Surgery·R P PapiniN Parkhouse
Apr 29, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Robert L Sheridan
Oct 27, 1998·Seminars in Ophthalmology·S L Hrabovsky
Mar 20, 2008·The Journal of Trauma·Laurie C D'AvignonLeopoldo C Cancio
Sep 20, 2011·The Journal of Trauma·Laurie C D'AvignonUNKNOWN Prevention of Combat-Related Infections Guidelines Panel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The Journal of Burn Care & Rehabilitation
M WrigleyP R Fine
The Journal of Burn Care & Rehabilitation
L AtilesC Baxter
© 2021 Meta ULC. All rights reserved